Physician profile
John Drexler
NPI 1548415268
$1,483.45
in general payments reported to CMS, 2019-2025
8 companies · $879 in 2025
The $879 reported for 2025 was more than what 93% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.12 · 2020: $11.80 · 2023: $145 · 2024: $432 · 2025: $879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,455.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $813.54 | 2023-2025 | Carto 3, Qdot Micro, Qdot Micro Catheter |
| Boston Scientific Corporation | $416.59 | 2024-2025 | Watchman Flx, Watchman Access System, Ekosonic |
| Medtronic, INC. | $77.43 | 2025 | Symplicity G3, Telescope, Onyx Frontier |
| Atricure, INC. | $51.24 | 2024 | |
| Merck Sharp & Dohme LLC | $44.96 | 2019-2023 | Bridion |
| Edwards Lifesciences Corporation | $35.15 | 2023-2025 | Sapien 3 Ultra Resilia, Pascal |
| Biotronik INC. | $29.91 | 2023 | Biomonitor |
| Lemaitre Vascular, INC. | $14.63 | 2024 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Drexler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.